Moderna has submitted a request to the FDA for emergency authorization of its mRNA COVID-19 vaccine for children 6 months to 5 years of age, the company said Thursday.
Moderna has submitted a request to the FDA for emergency authorization of its mRNA COVID-19 vaccine for children 6 months to 5 years of age, the company said Thursday.